Kwang-yu Chang
Tainan, TNQ 70456, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
KDM1A/HDAC2-driven epigenetic dysregulation maintains a drug-resistant, relapse-initiating glioblastoma cell niche at the peri-tumoral margin.
Journal: Biochemical pharmacology
Published: February 23, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-Arm, Phase Ib, Multicenter Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2025
Revealing the Roles of the SH3GLB1-Hydrogen Peroxide Axis in Glioblastoma Multiforme Cells.
Journal: Oncology research
Published: August 03, 2025
Correction: SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 27, 2025
SOD2-mediated TMZ-resistant Glioblastoma Cells Exhibit Cross-resistance to Irradiation.
Journal: Anticancer research
Published: June 11, 2025
Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cells.
Journal: Cancer immunology, immunotherapy : CII
Published: June 07, 2025
Contribution of Prostaglandin E2-Induced Neuronal Excitation to Drug Resistance in Glioblastoma Countered by a Novel Blood-Brain Barrier Crossing Celecoxib Derivative.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 08, 2025
A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumors.
Journal: Investigational new drugs
Published: March 17, 2025
Unraveling Cathepsin S regulation in interleukin-7-mediated anti-tumor immunity reveals its targeting potential against oral cancer.
Journal: Journal of biomedical science
Published: February 19, 2025
Neurotrophic factor Neuritin modulates T cell electrical and metabolic state for the balance of tolerance and immunity.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
Journal: Cell death & disease
Published: January 24, 2024
Last Updated: 09/26/2026